← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 5, 2019Last known activity
Feb 12, 2026
Timeline
2000s
- Mar 7, 2008
levoleucovorin— NDA Secondary Org
- Mar 7, 2008
levoleucovorin— Marketing Organization
2010s
- Jan 1, 2018
Acrotech Biopharma LLC— Founded
Drugs by trial phase (15 distinct, 11 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Marketed drugs (5)
Recent trials (16)
- NCT06072131Lead sponsorPhase 3Oct 4, 2023
- NCT06072131Study directorPhase 3Oct 4, 2023
- NCT07036133Lead sponsorPhase 1Dec 28, 2022
- NCT05608343Study directorPhase 3Oct 1, 2022
- NCT05608343Lead sponsorPhase 3Oct 1, 2022
- NCT05571943Study directorPhase 3Sep 15, 2022
- NCT05571943Lead sponsorPhase 3Sep 15, 2022
- NCT05170334CollaboratorPhase 2Dec 8, 2021
- NCT04703920CollaboratorPhase 1Mar 4, 2021
- NCT04448834CollaboratorPhase 2Dec 15, 2020
- NCT04315155CollaboratorPhase 1Sep 30, 2020
- NCT04315233CollaboratorPhase 1Aug 31, 2020
- NCT04243434Lead sponsorPhase 1Mar 15, 2020
- NCT04243434Study directorPhase 1Mar 15, 2020
- NCT04184869Lead sponsorPhase 1Aug 5, 2019
Details
- Founded
- East Windsor, NJ, US Jan 1, 2018
- Last known activity
- Feb 12, 2026